Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: BJOG. 2021 Jun 14;128(12):1986–1996. doi: 10.1111/1471-0528.16758

Table 3.

Histopathology result at one-year follow-up correlated with sequential high-risk HPV screening results among 236 women living with HIV

Histopathology result at one-year follow-up High-risk HPV + / high-risk HPV +
n = 31a
High-risk HPV + / high-risk HPV −
n = 36b
High-risk HPV − / high-risk HPV +
n = 15c
High-risk HPV − / high-risk HPV −
n = 154d
Benign 12 (39) 6 (17) 6 (40) 0 (0)
CIN1 9 (29) 1 (3) 1 (7) 1 (1)
CIN2 3 (10) 2 (6) 2 (13) 1 (1)
CIN3 7 (23) 1 (3) 6 (40) 0 (0)

Note: Excludes the 1 participant who was not eligible for colposcopy at one year due to pregnancy

a

Of the cases of CIN2 and CIN3 in this category, four had persistent HPV16 or 18, four had persistent other high-risk HPV, and two had cleared HPV16 but acquired other high-risk HPV at follow-up.

b

Only participants with indications underwent colposcopy according to the study protocol or clinical guidelines. These participants included: 8 who had CIN2 or higher at baseline, 1 with persistent low-grade cytology, and 1 with postmenopausal bleeding. The three cases of CIN2 or higher all had other high-risk HPV at baseline.

c

Of the cases of CIN2 and CIN3 in this category, seven were associated with other high-risk HPV and one with co-infection with HPV16 and HPV18.

d

Only women with indications underwent colposcopy. These participants included: one who had persistent low-grade cytology and one who had an abnormal cervical examination.